Results 151 to 160 of about 1,680,433 (254)

Hypertriglyceridemia‑Induced Acute Pancreatitis Compared With Non-Hypertriglyceridemia Acute Pancreatitis: A Retrospective Case-Control Study. [PDF]

Health Sci Rep
Farhangiyan Z, Moradi L, Vaziri M, Lak E, Zaman F, Mohammadi S.   +5 more
europepmc   +1 more source

Long non‐coding RNAs at the crossroads of inflammation, cancer and angiogenesis: Molecular mechanisms and their potential as therapeutic targets

British Journal of Pharmacology, EarlyView.
Long non‐coding RNAs (lncRNAs), a broad class of non‐protein‐coding RNAs, are characterized as new regulators of gene expression at the epigenetic, transcriptional, and post‐transcriptional level. Thus, lncRNAs are involved in the regulation of physiological processes and the development of human diseases and cancer by modulating proinflammatory ...
Charlie Leboff, Pamela Calle‐Mendoza, Maria Hatziapostolou, Christos Polytarchou   +3 more
wiley   +1 more source

Clinical Significance of a Cell‐Of‐Origin‐Based Classification in Pancreatic Ductal Adenocarcinoma

Cancer Science, EarlyView.
Schematic overview of a cell‐of‐origin‐based classification of pancreatic ductal adenocarcinoma (PDAC), highlighting distinct biological features and therapeutic implications of Acinar‐ and Ductal‐subtypes. ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with limited therapeutic options and poor clinical ...
Tatsuya Kikuchi, Soichiro Ako, Hironari Kato, Hideaki Kinugasa, Masaki Uchida, Takashi Oda, Ryosuke Hirai, Akihiro Matsumi, Kazuya Miyamoto, Hiroyuki Terasawa, Yuki Fujii, Daisuke Uchida, Kazuyuki Matsumoto, Koichiro Tsutsumi, Shigeru Horiguchi, Kazuya Yasui, Tomokazu Fuji, Kosei Takagi, Hirokazu Kato, Tomoyuki Honda, Fumio Otsuka, Motoyuki Otsuka   +21 more
wiley   +1 more source

Endoscopic Ultrasound‐Guided Ethanol Ablation for Benign Insulinoma: A Single‐Centre Experience and Literature Review

Clinical Endocrinology, EarlyView.
ABSTRACT Objectives Insulinoma is a predominantly benign pancreatic neuroendocrine tumour that is traditionally managed surgically. However, surgical invasiveness and anaesthesia‐related risks limit its applicability in selected patients. Endoscopic ultrasound (EUS)‐guided ethanol ablation has emerged as a minimally invasive alternative.
Yuchao Wu, Haitao Shi, Xiaokang Wu, Ying Kong, Xueqian Li, Lijing Yan, Juanjuan Wu, Shimei Ding, Jing Zhang, Ruo Zhang, Chunhong Zhang, Jing Xu, Aiyu Jing, Xuan Xie, Shiyang Ma, Yang Jiao   +15 more
wiley   +1 more source

Research advances in hypertriglyceridemia-induced acute pancreatitis. [PDF]

Front Med (Lausanne)
Cai Y, Huang X.
europepmc   +1 more source

Unveiling the multidimensional cytokine landscape in acute pancreatitis. [PDF]

Front Immunol
Kosidło JW, Dorf J, Kamińska J, Koper-Lenkiewicz OM, Żaczek M, Saniuk P, Zimnoch K, Panasiuk A, Matowicka-Karna J.   +8 more
europepmc   +1 more source

User satisfaction with fingerstick versus continuous glucose monitoring in surgical wards: A two‐centre non‐randomised clinical trial

Diabetic Medicine, EarlyView.
Abstract Aims To compare person‐reported outcomes on point‐of‐care (POC) fingerstick glucose monitoring (FSGM) with POC continuous glucose monitoring systems (CGMS) in adults admitted to surgical wards. The primary outcome was convenience; the secondary outcome was satisfaction with diabetes‐related treatment.
Tine Lumbye Thomsen, Marian Christin Petersen, Line Abrahamsen, Torill Donslund Nielsen, Karoline Schousboe, Sören Möller, Helen Schultz   +6 more
wiley   +1 more source

Trajectories of Glycemia Following Acute Pancreatitis: A Prospective Longitudinal Study. [PDF]

Cureus
Krishna UV, Gowrishankar B, Chowdary MTV, Yadav VD, Girinadh L, Kinneresh R.   +5 more
europepmc   +1 more source

Indocyanine Green Fluorescence Cholangiography With Selective Intraoperative Cholangiography: A Proposed Standard for Laparoscopic Cholecystectomy

ANZ Journal of Surgery, EarlyView.
Jaswinder S. Samra, Krishna Kotecha, Anubhav Mittal   +2 more
wiley   +1 more source

Real‐world observational study evaluating metabolic and kidney outcomes in patients living with chronic kidney disease and type 2 diabetes mellitus with obesity prescribed tirzepatide

Diabetic Medicine, EarlyView.
Abstract Background Obesity and type 2 diabetes mellitus (T2DM) accelerate chronic kidney disease (CKD) progression. Tirzepatide, a dual glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonist, has demonstrated metabolic and potential renoprotective benefits in clinical trials.
Jack E. Carruthers, Xi Yan Ooi, Dawn Goodall, Jo Reed, Rachna Bedi, Adrian McGrath, Michelle Willicombe, Parizad Avari, Andrew H. Frankel   +8 more
wiley   +1 more source